MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
available-for-sale
$487,568K
Cash and cash
equivalents
$160,247K
Inventories
$73,288K
Accounts receivables,
net of allowance for...
$72,359K
Prepaid expenses and
other current assets
$19,907K
Other receivables
$962K
Total current assets
$814,331K
Other assets, net of
allowance for doubtful...
$64,217K
Property and equipment,
net
$45,855K
Operating lease
right-of-use assets
$19,904K
Goodwill
$2,199K
Total assets
$946,506K
Total liabilities and
stockholders equity
$946,506K
Total stockholders
equity
$534,138K
Total liabilities
$412,368K
Accumulated deficit
-$953,726K
Additional paid-in capital
$1,486,947K
Convertible notes, net of
debt discount of...
$220,966K
Total current
liabilities
$106,839K
Cepi accrual
long-term (note 6)
$60,337K
Long-term portion of lease
liabilities
$23,985K
Other long-term
liabilities
$241K
Accumulated other
comprehensive income
$800K
Common stock 0.001 par
value, 278,000 shares...
$117K
Accrued liabilities
$51,889K
Convertible notes, current
portion, net of debt...
$40,073K
Accrued research and
development
$6,697K
Other current
liabilities
$4,232K
Accounts payable
$3,948K
Back
Back
Balance Sheet
source: myfinsight.com
DYNAVAX TECHNOLOGIES CORP (DVAX)
DYNAVAX TECHNOLOGIES CORP (DVAX)